Sign inJoin waitlistJoin the waitlist

Timothy R. Sterling

Infectious Disease · Vanderbilt University Medical Center

Credentials: · · · ·

History

Johns Hopkins Hospital and Health System
Until 1998
Columbia Presbyterian Medical Center
Until 1992
Columbia University
1989

Research

The emergence of drug-resistant tuberculosis in New York City
New England Journal of Medicine · 1993 · 779 citations
Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy
PLoS ONE · 2016 · 94 citations
Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative…
Clinical Infectious Diseases · 2016 · 57 citations

AJ
Amy Justice
4 papers
Heidi Crane
4 papers
MH
Michael Horberg
4 papers
RM
Richard Moore
4 papers
Jennifer Thorne
3 papers
Elizabeth Humes
2 papers · 1 as a fellow
Gregory Kirk
2 papers
Mari Kitahata
2 papers
Michael Saag
2 papers
TF
Thomas Frieden
2 papers
Amita Gupta
1 paper
Ank Nijhawan
1 paper

Clinical trials

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
Study chair · Recruiting · Phase 2, Phase 3
Centers for Disease Control and Prevention
2019–2029
Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection
Study chair · Completed · Phase 3
Centers for Disease Control and Prevention
2001–2013